Our product is a non-invasive pain-blocking

system which offers an alternative to tradi-

tional local anesthesia (Lidocaine injec-

tions), with no needle-punctures. This

pioneering technology provides a full

anesthetic effect through application of

electrical energy via a set of electrodes

strategically placed on the surface of the

skin. We are excited to capture several exist-

ing market segments, including providing

pain-free local anesthesia during finger/hand surgeries

and repair and dental operations, as well as opening new

markets for pediatric (and adult) skin numbing prior to injec-

tions of vaccines, venous blood draws, or placement of IV

catheters. At Asensus, we believe that anesthesia should be

pain free.

se susPain-free nerve block

MARKET

Broad application in growing outpatient, inpatient and dental markets

Available market sizes range from $12M - $23B per segment (2.5%-20% of total markets, international)

Facile penetration in outpatient markets with clear cost structure

Competing devices only offer low-level, transient pain reduction (e.g. TENS, BUZZY)

�

�

�

MILESTONES ACHIEVED

Provisional patent secured

Identified predicate for 510k regulatory pathway (TENS unit)

Functional testing with prototype

ü

ü

ü

�

S�mulator sales (one-�me): $1,000 /ea (87% profit margin)

Disposable electrode sales (recurring): $10 /ea (35% profit margin)

Contact us: asens.us

Startup CostsS�mulator

Electronics design $50,000

Enclosure design $20,000

Power supply design $40,000

UI design $20,000

Packaging design $10,000

Labeling design $10,000

TOTAL: $150,000

ElectrodesMold design $20,000

Packaging design $10,000

Labeling design $10,000

TOTAL: $40,000

OtherProcess/supply chain design $50,000

Func�onal tes�ng $100,000

Regulatory work $200,000

TOTAL: $350,000

Startup costs total: $540,000.00

Revenues: Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

S�mulator Sales $0 $0 $25,000 $50,000 $100,000 $200,000 $400,000 $700,000 $1,100,000 $2,000,000

Electrode Sales $0 $0 $12,500 $37,500 $87,500 $187,500 $387,500 $725,000 $1,250,000 $2,200,000

Total Revenues $0 $0 $37,500 $87,500 $187,500 $387,500 $787,500 $1,425,000 $2,350,000 $4,200,000

Expenses:

Produc�on:

Startup costs (fixed) $245,000 $245,000 $50,000 $0 $0 $0 $0 $0 $0 $0

S�mulator (variable) COGS $0 $0 $3,375 $6,750 $13,500 $27,000 $54,000 $94,500 $148,500 $270,000

Electrode (variable) COGS $0 $0 $8,125 $24,375 $56,875 $121,875 $251,875 $471,250 $812,500 $1,430,000

Total Produc�on Costs $245,000 $245,000 $61,500 $31,125 $70,375 $148,875 $305,875 $565,750 $961,000 $1,700,000

Overhead:

Wages (admin, sales) $0 $0 $50,000 $100,000 $150,000 $200,000 $200,000 $250,000 $300,000 $300,000

Rent $0 $0 $0 $20,000 $20,000 $20,000 $30,000 $30,000 $40,000 $40,000

U�li�es $0 $0 $0 $5,000 $5,000 $5,000 $7,000 $7,000 $10,000 $10,000

Supplies $0 $0 $2,000 $2,000 $2,500 $3,000 $3,000 $3,500 $4,000 $4,000

Adver�sing/marke�ng $0 $0 $30,000 $40,000 $50,000 $60,000 $70,000 $80,000 $90,000 $100,000

Debt repayment $0 $0 $0 $0 $0 $0 $0 $0 $0 $0

Total Overhead Costs $0 $0 $82,000 $167,000 $227,500 $288,000 $310,000 $370,500 $444,000 $454,000

Total Expenses $245,000 $245,000 $143,500 $198,125 $297,875 $436,875 $615,875 $936,250 $1,405,000 $2,154,000

Net Income -$245,000 -$245,000 -$106,000 -$110,625 -$110,375 -$49,375 $171,625 $488,750 $945,000 $2,046,000

Forcasted Income

-$250,000

$0

$250,000

$500,000

$750,000

$1,000,000

$1,250,000

$1,500,000

$1,750,000

$2,000,000

$2,250,000

1 2 3 4 5 6 7 8 9 10

Years of Opera�on

Ne

t In

com

e

Break Even

Projected Net Income